From Early Chemistry To The GLP-1 Era: How Peptides Became Cornerstones Of Modern Medicine

Over the past century, peptides have transformed from theoretical chemical constructs into a cornerstone of modern therapeutics, enabling highly targeted treatments across a wide range of diseases. Their unique position between small molecules and biologics allows them to deliver exceptional specificity while interacting with complex biological pathways that traditional drugs often cannot reach. Early breakthroughs, including the discovery of insulin, demonstrated both the clinical power and development challenges of peptide-based therapies, establishing a foundation for future innovation. Advances in synthesis technologies, formulation strategies, and delivery methods have since expanded their utility, improving stability and enabling scalable production. Today, the rise of GLP‑1 receptor agonists underscores how decades of scientific progress have converged to unlock new therapeutic potential, positioning peptides as a critical and continually evolving modality in drug development.